Recombinant Human TMEM26 Protein，GST

TMEM26, or Transmembrane Protein 26, is an integral membrane protein that has garnered interest in recent years due to its potential roles in various biological processes and disease mechanisms. Initially identified as a gene associated with cancer and metabolic disorders, studies have suggested that TMEM26 may play a critical role in cellular pathways, including those related to inflammation, cell proliferation, and apoptosis. The protein is thought to be involved in the regulation of cellular stress responses, making it a potential target for therapeutic interventions. Its expression is notable in several tissue types, and aberrations in TMEM26 levels have been linked to pathological conditions, including tumors and neurodegenerative diseases. Given these associations, researchers have focused on characterizing TMEM26 through recombinant protein expression, which allows for detailed functional studies and structural analysis. This research aims to elucidate the mechanistic roles of TMEM26 in normal physiology and disease states, providing insights that may lead to novel therapeutic strategies targeting this protein. Understanding the structure and function of TMEM26 could pave the way for advancements in treatment options for cancer and other TMEM26-related disorders. As such, the study of TMEM26 is not only fundamental for basic biological research but also has significant clinical implications.